Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1191 for “"Targeted therapies"”.
-
Targeted therapies in mantle cell lymphoma
… Rituximab is a chimeric monoclonal antibody targeted against B cells and both Rituximab-sensitive and insensitive MCL models were defined. An abnormally high expression of bcl-2, bcl-x L, mcl-1, CD40/CD40L and Fas were observed in all MCL cells, as well as high levels of soluble FasL, capable …
-
Microbiome Targeted Therapies in Gulf War Illness
Gulf war illness (GWI) is a chronic multisymptomatic disorder affecting about 30% of veterans of the 1990-1991 Persian Gulf war. Affected veterans complain of chronic symptoms which begun during or shortly after the war and persist 30 years later. This dissertation is a report of three studies …
-
ATM-deficient cancer cells and targeted therapies
The driving principle behind precision medicine is to specifically target genetic variations that arise in tumorigenesis while leaving normal cells unaffected. Mutations in Ataxia Telangiectasia Mutated (ATM) may offer such a therapeutic target. ATM is mutated in a variety of tumor types and these …
-
Targeted therapies for adult acute lymphoblastic leukemia
Η θεραπεία της οξείας λεμφοβλαστικής λευχαιμίας με μονοκλωνικά αντισώματα είναι στοχευμένη/ εξειδικευμένη, με διαφορετικό μηχανισμό δράσης από την χημειοθεραπεία και διαφορετικές παρενέργειες. Ο συνδυασμός των στοχεμένων θεραπειων με την χημειοθεραπεία μειώνει τον κινδυνο υποτροπής της νόσου.
-
Targeted therapies for the treatment of solid cancers
… new therapeutics for cancer, particularly therapies targeted to specific molecular subtypes, which have resulted in significantly improved patient survival. However, for some types of solid cancers there have been no significant recent improvements in patient survival or development of …
-
Mechanisms of medulloblastoma vulnerability and new targeted therapies
… there is an urgent need for developing new targeted therapies.The aim of this PhD research was focused on expanding the knowledge of MB biology and providing tailored therapeutic options to be used in the clinic:Project 1. A well-defined feature of MB is the genetic alterations of the cell …
-
Developing Targeted Therapies for T-cell Acute Lymphoblastic Leukemia
… common cancer in children, and risk-adapted chemotherapies have dramatically improved the outcomes of this disease. Compared to B-cell ALL, T-cell ALL (T-ALL) is more aggressive and has worse outcomes from chemotherapy. There is a great unmet need to develop biomarkers and novel targeted therapies …
-
Exploring new targeted therapies for Sonic Hedgehog (SHH) medulloblastoma
… either alone or in combination with other targeted therapies for the treatment of SHH MB.
-
Exploring new targeted therapies for sonic hedgehog (SHH) medulloblastoma
… the bulk of treatment failures. Few personalized therapies for SHH MB exist, as SHH pathway antagonists are predicted to be ineffective in younger patients with tumors harbouring mutations in downstream SHH pathway genes. Novel, targeted therapies that have the possibility to reduce toxicity and …
-
Cancer Heterogeneity and Mitochondrial-Targeted Therapies in Cancer Cachexia
Cancer Cachexia (CC) is a multifactorial and complex syndrome affecting up to 80% of cancer patients and contributing to approximately 40% of cancer-related deaths. Given its relationship with patients' quality of life and prognosis, there has been increasing emphasis on understanding the …
-
Economic Evaluations of Companion Cancer Biomarkers for Targeted Therapies
Background: Companion biomarkers for targeted therapies have increased the expectation that biomarkers can improve health outcomes or potentially save health resources without compromising patient outcomes. However, few countries provide health economic assessment methods guidance (e.g. health …
-
The role of miRNAs in resistance to HER2 targeted therapies
… of innate and/or acquired resistance to HER2 targeted therapies. All-trans retinoic acid (ATRA) treatment alone or in combination with trastuzumab or lapatinib may overcome resistance in some HER2 positive breast tumours. Co-amplification of retinoic acid receptor alpha (RARα) with HER2 may be …
-
TARGETED THERAPIES FOR EWSR1-FLI1 TRANSLOCATED EWING FAMILY OF TUMORS
… druggable, driving the need for more effective targeted therapies. The EWSR1-FLI1 translocation induces a variety of changes including dysregulation of the epigenome and altered gene expression to drive tumorigenesis, and consequently contributes to the hypersensitivity of EWFT to several …
-
INTRODUCING NOVEL COMBINATORIAL TARGETED THERAPIES IN MULTIPLE TYPES OF CANCER
The cancers of liver, colon and breast are amongst the top five most prevalent and most fatal worldwide. As the Raf/MEK/ERK pathway is frequently deregulated in hepatocellular carcinoma (HCC), sorafenib, a Raf kinase inhibitor, became the first systemic therapy approved for the treatment of …
-
Targeted therapies for obstructive sleep apnoea: A physiology-based approach
… endotypes. Current anatomical-orientated therapies are often inadequate or poorly tolerated with no pharmacotherapies available for OSA. Recent research shows that a combination of noradrenergic and anti-muscarinic agents increases upper-airway muscle activity (key non-anatomical endotype) …
-
Resistance to HER2-targeted therapies in HER2-positive breast cancer
… cancers, but the development of HER2-targeted therapies led to significant survival improvements. Despite this, patients often present with de novo resistance, or will develop acquired resistance to targeted therapies. Several resistance mechanisms have been identified but attempts to …
-
High-mannose N-glycans in breast cancer: Implications for targeted therapies
… to rise annually, despite advancements in targeted therapies. These treatments are not universally effective, can be accompanied by drug toxicity, and nearly all patients eventually develop therapeutic resistance. Additionally, therapeutic options for patients with the most aggressive forms …
Page 1 of 60